Title: | Food and Drug Administration's drug approval process |
Alternate title: | FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005. |
Author: | United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions |
Note: | U.S. G.P.O. :, 2005 |
Link: | page images at HathiTrust |
No stable link: | This is an uncurated book entry from our extended bookshelves, readable online now but without a stable link here. You should not bookmark this page, but you can request that we add this book to our curated collection, which has stable links. |
Subject: | Drugs -- United States -- Testing |
Subject: | Pharmaceutical policy -- United States |
Subject: | United States. Food and Drug Administration |
Other copies: | Look for editions of this book at your library, or elsewhere. |
Help with reading books -- Report a bad link -- Suggest a new listing
Home -- Search -- New Listings -- Authors -- Titles -- Subjects -- Serials
Books -- News -- Features -- Archives -- The Inside Story
Edited by John Mark Ockerbloom (onlinebooks@pobox.upenn.edu)
OBP copyrights and licenses.